tirzepatide cardiovascular outcome Tirzepatide vs Dulaglutide in Type 2 Diabetes Patients tirzepatide and cardiovascular outcomes ๐
Description
Weight management is not cosmetic
The relationship is exponential, meaning each additional degree causes proportionally more damage than the last
& Stuber, G
Yes, certain individuals experience further or continued weight loss after switching treatments
Tirzepatide slows gastric emptying, so rapid eating or overeating can cause nausea because the stomach hasn't had proper time to digest and empty, Dr
Conclusion GLP-1 medications can reduce hunger and slow gastric emptying, which helps you eat less, but it can also make it easier to under-eat protein and lose muscle tissue if you stop training
